Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03345836
Other study ID # M14-431
Secondary ID 2017-001226-18
Status Completed
Phase Phase 3
First received
Last updated
Start date November 29, 2017
Est. completion date August 11, 2021

Study information

Verified date July 2022
Source AbbVie
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and severely active Crohn's disease (CD).


Recruitment information / eligibility

Status Completed
Enrollment 624
Est. completion date August 11, 2021
Est. primary completion date August 11, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Confirmed diagnosis of CD for at least 3 months prior to Baseline. - Confirmed diagnosis of moderate to severe CD as assessed by stool frequency (SF), abdominal pain (AP) score. - Evidence of mucosal inflammation based on the Simplified Endoscopic Score for Crohn's disease (SES-CD) on an endoscopy confirmed by a central reader. - Demonstrated an inadequate response or intolerance to any biologic therapy for infliximab, adalimumab, certolizumab pegol, vedolizumab, and ustekinumab. - If female, participant must meet the contraception recommendations. Exclusion Criteria: - Participant with a current diagnosis of ulcerative colitis or indeterminate colitis. - Participant not on stable doses of CD related antibiotics, oral aminosalicylates, corticosteroids or methotrexate (MTX). - Participant with the following ongoing known complications of CD: abscess (abdominal or peri-anal), symptomatic bowel strictures, fulminant colitis, toxic megacolon, or any other manifestation that might require surgery while enrolled in the study. - Participant with ostomy or ileoanal pouch. - Participant diagnosed with conditions that could interfere with drug absorption including but not limited to short gut or short bowel syndrome. - Screening laboratory and other protocol pre-specified analyses show abnormal results.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Matching Placebo for Upadacitinib
Matching placebo tablets
Upadacitinib
Upadacitinib tablets

Locations

Country Name City State
Argentina Hospital Italiano de Buenos Aires /ID# 215543 Ciudad Autonoma Buenos Aires Ciuadad Autonoma De Buenos Aires
Argentina Cemic /Id# 169184 Ciudad Autonoma de Buenos Aire Ciuadad Autonoma De Buenos Aires
Argentina Gedyt /ID# 210019 Ciudad Autonoma de Buenos Aire Ciuadad Autonoma De Buenos Aires
Argentina Hospital Privado Univesitario /ID# 169228 Cordoba
Argentina Hospital Provincial del Centenario /ID# 171254 Rosario Santa Fe
Argentina Cardio Alem /ID# 211284 San Isidro Buenos Aires
Australia Royal Adelaide Hospital /ID# 171511 Adelaide South Australia
Australia Box Hill Hospital /ID# 203734 Box Hill Victoria
Australia Concord Repatriation General Hospital /ID# 171509 Concord New South Wales
Australia Fiona Stanley Hospital /ID# 171510 Murdoch Western Australia
Australia Coral Sea Clinical Research institute /ID# 212987 North Mackay Queensland
Australia Mater Misericordiae Limited /ID# 204908 South Brisbane Queensland
Austria Landeskrankenhaus Salzburg-Universitätsklinikum der PMU (LKH) /ID# 214467 Salzburg
Austria Klinik Landstrasse /ID# 203437 Vienna Wien
Austria Medizinische Universitaet Wien /ID# 169462 Vienna Wien
Belgium AZ Sint-Lucas /ID# 200301 Gent
Belgium CHU UCL Namur - site Godinne /ID# 200300 Godinne Namur
Belgium Universitair Ziekenhuis Leuven /ID# 200298 Leuven Vlaams-Brabant
Belgium CHU de Liege Sart Tilman /ID# 200299 Liège Liege
Belgium UCL Saint-Luc /ID# 200297 Woluwe-Saint-Lambert Bruxelles-Capitale
Bosnia and Herzegovina University Clinical Centre of the Republic of Srpska /ID# 208050 Banja Luka Republika Srpska
Bosnia and Herzegovina Clinical Center University of Sarajevo /ID# 203885 Sarajevo
Bosnia and Herzegovina Polyclinic and Daily Hospital Dr. Al-Tawil /ID# 217841 Sarajevo
Bosnia and Herzegovina University Clinical Center Tuzla /ID# 210324 Tuzla Tuzlanski
Brazil Upeclin Fmb - Unesp /Id# 166876 Botucatu Sao Paulo
Brazil Hospital Nossa Senhora das Graças /ID# 166869 Curitiba Parana
Brazil Instituto Goiano de Gastroenterologia e Endoscopia Digestiva /ID# 166870 Goiânia Goias
Brazil Hospital de Clinicas de Porto Alegre /ID# 166872 Porto Alegre Rio Grande Do Sul
Brazil Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP /ID# 166874 Ribeirão Preto Sao Paulo
Brazil Faculdade de Medicina do ABC /ID# 208327 Santo André Sao Paulo
Brazil Kaiser Clinica e Hospital Dia /ID# 166873 Sao Jose Do Rio Preto Sao Paulo
Bulgaria UMHAT Kaspela EOOD /ID# 167617 Plovdiv
Bulgaria Duplicate_Second MHAT Sofia /ID# 167618 Sofia
Bulgaria MHAT Trakia /ID# 201678 Stara Zagora
Canada University of Calgary - Cumming School of Medicine - Adult Cystic Fibrosis Clini /ID# 166963 Calgary Alberta
Canada Allen Whey Khye Lim Professional Corporation /ID# 168041 Edmonton Alberta
Canada Covenant Health /ID# 166966 Edmonton Alberta
Canada QEII - Health Sciences Centre /ID# 169306 Halifax Nova Scotia
Canada CHAU- Hotel-Dieu de Levis /ID# 166958 Levis Quebec
Canada Crchum /Id# 170121 Montreal Quebec
Canada Montreal General Hospital - McGill University Health Center /ID# 170010 Montreal Quebec
Canada Fraser Clinical Trials Inc /ID# 166957 New Westminster British Columbia
Canada Scott Shulman Medicine Professional Corporation /ID# 169064 North Bay Ontario
Canada Taunton Surgical Centre /ID# 168039 Oshawa Ontario
Canada The Ottawa Hospital /ID# 212413 Ottawa Ontario
Canada CIUSSS de l'Estrie - CHUS /ID# 170935 Sherbrooke Quebec
Canada Medicor Research Inc /ID# 166967 Sudbury Ontario
Canada GIRI Gastrointestinal Research Institute /ID# 166964 Vancouver British Columbia
Canada Toronto Digestive Disease Asso /ID# 166961 Vaughan Ontario
Chile Hospital Guillermo Grant Benavente de Concepción /ID# 212422 Concepción
Chile CTR Estudios Clinicos /ID# 200650 Providencia
Chile Hospital Clinico Universidad De Los Andes /ID# 207465 Santiago
Chile M y F Estudios Clínicos /ID# 169995 Santiago Region Metropolitana Santiago
Chile Research Group /ID# 203180 Santiago Region Metropolitana De Santiago
China Beijing Friendship Hospital /ID# 204536 Beijing
China The First Hospital of Jilin University /ID# 206867 Changchun Jilin
China The Second Hospital Central South University /ID# 204075 Changsha
China Zhongshan Hospital Xiamen University /ID# 204985 Fujian Anhui
China Nanfang Hospital of Southern Medical University /ID# 204074 Guangzhou
China Sun Yat-sen Memorial Hospital of Sun Yat-sen University /ID# 205226 Guangzhou Guangdong
China The Sixth Affiliated Hosp Sun /ID# 204049 Guangzhou Guangdong
China Sir Run Run Shaw Hospital,Meical School Zhejiang University /ID# 204068 Hangzhou Zhejiang
China The second Affiliated hospital of Zhejiang University school of Medicine /ID# 204078 Hangzhou Zhejiang
China The First Affiliated Hospital of Nanchang University /ID# 204070 Nanchang Jiangxi
China Nanjing Drum Tower Hospital /ID# 204869 Nanjing Jiangsu
China Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 204072 Shanghai Shanghai
China Duplicate_Tianjin Med Univ General Hosp /ID# 206993 Tianjin
China Tongji Hospital Tongji Medical College Huazhong University of Science and Techno /ID# 204069 Wuhan
China Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 204096 Wuhan Hubei
Colombia Hospital San Vicente de Paul /ID# 200028 Medellin Antioquia
Colombia Hospital Pablo Tobon Uribe /ID# 202405 Medellín Antioquia
Croatia UHC Split /ID# 171206 Split
Croatia Zadar General Hospital /ID# 205534 Zadar
Croatia Clinical Hospital Dubrava /ID# 171186 Zagreb Grad Zagreb
Croatia Klinicki bolnicki centar Sestre milosrdnice /ID# 171190 Zagreb Grad Zagreb
Croatia Klinicki bolnicki centar Zagreb /ID# 171201 Zagreb Grad Zagreb
Croatia Poliklinika Solmed /ID# 211518 Zagreb Grad Zagreb
Czechia Hepato-Gastroenterologie HK, s.r.o. /ID# 171566 Hradec Kralove
Czechia ResTrial s.r.o. /ID# 208652 Praha
Czechia ARTROSCAN s.r.o. /ID# 171592 Trebovice
Denmark Nordsjaellands Hospital /ID# 200613 Frederikssund Hovedstaden
Denmark Herlev Hospital /ID# 200782 Herlev Hovedstaden
Denmark Kobenhavns Universitet - Hvidovre Hospital (HH) /ID# 200611 Hvidovre Hovedstaden
Denmark Duplicate_Sjaellands Universitets Hospital /ID# 200783 Roskilde Sjælland
Egypt Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 171010 Alexandria
Egypt Clinical Research Center, Faculty of Medicine, Alexandria university. /ID# 171015 Alexandria
Egypt Air Force Specialized Hospital /ID# 170995 Cairo
Egypt Clinical Research Center, Faculty of Medicine, Cairo university /ID# 209557 Cairo
Egypt Faculty of Medicine Ain Shams Research Institute- Clinical Research Centre /ID# 209565 Cairo
Egypt National Hepatology and Tropical Medicine Research Institute /ID# 170990 Cairo
Estonia Tartu University Hospital /ID# 203140 Tartu Linn Tartumaa
France CHU Amiens-Picardie Site Sud /ID# 171016 Amiens CEDEX 1 Somme
France CHRU Tours - Hopital Trousseau /ID# 169786 Chambray Les Tours
France Hopital Beaujon /ID# 171011 Clichy Ile-de-France
France Duplicate_CHU Henri Mondor /ID# 169787 Creteil
France CHRU Lille - Hopital Claude Huriez /ID# 206539 Lille Hauts-de-France
France Duplicate_Hopital Saint Eloi /ID# 170646 Montpellier CEDEX 5 Herault
France Chu de Nice-Hopital L'Archet Ii /Id# 171009 Nice Alpes-Maritimes
France Polyclinique Grand Sud /ID# 170649 Nimes Cedex
France CHU Bordeaux - Hopital Haut Lévêque /ID# 207414 Pessac CEDEX Gironde
France HCL - Hôpital Lyon Sud /ID# 171014 Pierre Benite CEDEX Auvergne-Rhone-Alpes
France CHU de SAINT ETIENNE - Hopital Nord /ID# 171018 St. Priest En Jarez Loire
France CHU Toulouse - Hopital Rangueil /ID# 169785 Toulouse
France CHRU Nancy - Hôpitaux de Brabois /ID# 170985 Vandœuvre-lès-Nancy Meurthe-et-Moselle
Germany Charite Universitaetsklinikum Berlin - Campus Benjamin Franklin /ID# 169067 Berlin
Germany Gastroenterologie am Mexikoplatz /ID# 203573 Berlin
Germany Universitaetsklinikum Erlangen /ID# 203551 Erlangen Bayern
Germany Universitaetsmedizin Essen St. Josef Krankenhaus Werden /ID# 203571 Essen
Germany Agaplesion Markus Krankenhaus /ID# 168777 Frankfurt am Main
Germany Universitaetsklinikum Frankfurt /ID# 203565 Frankfurt am Main Hessen
Germany Universitaetsklinikum Halle (Saale) /ID# 207454 Halle (Saale)
Germany Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 168779 Kiel Schleswig-Holstein
Germany Universitatsklinikum Mannheim /ID# 168778 Mannheim Baden-Wuerttemberg
Germany Medizinisches Versorgungszentrum Portal 10 /ID# 200213 Muenster
Germany Zentrum für Gastroenterologie Saar MVZ GmbH /ID# 206740 Saarbrücken Saarland
Germany Universitaetsklinikum Ulm /ID# 203563 Ulm Baden-Wuerttemberg
Greece General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 167037 Athens
Greece General Hospital of Athens Ippokratio /ID# 167036 Athens Attiki
Greece General Hospital of Chest Diseases of Athens SOTIRIA /ID# 202103 Athens Attiki
Greece University General Hospital of Heraklion PA.G.N.I /ID# 167035 Heraklion Kriti
Greece Tzaneio general hospital of Piraeus /ID# 206432 Piraeus Attiki
Greece Genl Hosp Thess Ippokrateio /ID# 208824 Thessaloniki
Hong Kong Queen Mary Hospital /ID# 171217 Hong Kong
Hungary Magyar Honvedseg Egeszsegugyi Kozpont /ID# 201719 Budapest
Hungary Obudai Egeszsegugyi Centrum Kft. /ID# 201891 Budapest Pest
Hungary Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz /ID# 201720 Debrecen
Hungary Bugat Pal Korhaz /ID# 201889 Gyöngyös Heves
Hungary CRU Hungary Egeszsegugyi és Szolgaltato Kft. /ID# 205546 Miskolc Borsod-Abauj-Zemplen
Hungary Mentahaz Maganorvosi Kozpont /ID# 201890 Szekesfehervar
Ireland Mercy University Hospital /ID# 206510 Cork
Israel Barzilai Medical Center /ID# 223372 Ashkelon
Israel Soroka University Medical Center /ID# 169912 Be'er Sheva HaDarom
Israel Assaf Harofeh Medical Center /ID# 204870 Be'Er Ya'Akov
Israel Hadassah Medical Center-Hebrew University /ID# 169927 Jerusalem
Israel Rabin Medical Center /ID# 202635 Petakh Tikva
Israel Kaplan Medical Center /ID# 170277 Rehovot
Israel Tel Aviv Sourasky Medical Center /ID# 204876 Tel Aviv-Yafo Tel-Aviv
Italy A.O.U. di Bologna Policlinico S.Orsola-Malpighi /ID# 168173 Bologna
Italy A.O. Per L'Emergenza Cannizzaro /ID# 168176 Catania
Italy University of Catanzaro /ID# 201920 Catanzaro Calabria
Italy Policlinico San Martino/Univer /ID# 168177 Genova
Italy ASST Fatebenefratelli Sacco - Ospedale Fatebenefratelli e Oftalmico /ID# 168167 Milano
Italy Azienda Ospedaliero-Universitaria di Modena /ID# 200008 Modena
Italy IRCCS Ospedale Sacro Cuore Don Calabria /ID# 168172 Negrar Verona
Italy A.O. Ospedali Riuniti Villa Sofia - Cervello /ID# 168175 Palermo
Italy Azienda Ospedaliero Universitaria Pisana-Stabilimento di Cisanello /ID# 202420 Pisa
Italy Azienda Ospedaliera San Camillo Forlanini /ID# 168170 Rome Lazio
Italy Fondazione PTV Policlinico Tor Vergata /ID# 168174 Rome Roma
Italy Policlinico Universitario Campus Bio-Medico /ID# 168169 Rome Lazio
Italy Presidio Columbus-Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Un /ID# 168168 Rome Roma
Italy Istituto Clinico Humanitas /ID# 168171 Rozzano Milano
Japan Asahikawa Medical University Hospital /ID# 167133 Asahikawa-shi Hokkaido
Japan Tokyo Medical And Dental University, Medical Hospital /ID# 165948 Bunkyo-ku Tokyo
Japan NHO Fukuyama Medical Center /ID# 167139 Fukuyama-shi Hiroshima
Japan Duplicate_Tokai University Hachioji Hospital /ID# 165951 Hachioji-shi Tokyo
Japan Hirosaki National Hospital /ID# 165944 Hirosaki-shi Aomori
Japan Hiroshima University Hospital /ID# 166006 Hiroshima-shi Hiroshima
Japan Idzuro Imamura Hospital /ID# 206651 Kagoshima-shi Kagoshima
Japan Imamura General Hospital /ID# 227136 Kagoshima-shi Kagoshima
Japan Sameshima Hospital /ID# 206674 Kagoshima-shi Kagoshima
Japan Kanazawa University Hospital /ID# 169215 Kanazawa-shi Ishikawa
Japan Nara Medical University Hospital /ID# 169216 Kashihara-shi Nara
Japan Aoyama Clinic /ID# 166001 Kobe-shi Hyogo
Japan Chikuba Hospital for Proctological and Gastrointestinal Diseases /ID# 166002 Kurashiki-shi Okayama
Japan Kurume University Hospital /ID# 166004 Kurume-shi Fukuoka
Japan Japanese Red Cross Kyoto Daiichi Hosital /ID# 165958 Kyoto-shi Kyoto
Japan Kyoto University Hospital /ID# 169888 Kyoto-shi Kyoto
Japan The Jikei University Hospital /ID# 167142 Minato-ku Tokyo
Japan Kyorin University Hospital /ID# 165950 Mitaka-shi Tokyo
Japan Iwate Medical University Uchimaru Medical Center /ID# 202407 Morioka-shi Iwate
Japan Aichi Medical University Hospital /ID# 165957 Nagakute-shi Aichi
Japan Nagoya City University Hospital /ID# 165956 Nagoya shi Aichi
Japan Nagoya University Hospital /ID# 165955 Nagoyashi Aichi
Japan Niigata University Medical & Dental Hospital /ID# 170044 Niigata-shi Niigata
Japan Hyogo College of Medicine College Hospital /Id# 200173 Nishinomiya-shi Hyogo
Japan Ishida Clinic of IBD and Gastroenterology /ID# 167134 Oita-shi Oita
Japan Okayama University Hospital /ID# 167355 Okayama-shi Okayama
Japan Kinshukai Infusion Clinic /ID# 218871 Osaka-shi Osaka
Japan Osaka City University Hospital /ID# 166007 Osaka-shi Osaka
Japan Shiga University of Medical Science Hospital /ID# 167141 Otsu-shi Shiga
Japan Tokitokai Tokito clinic /ID# 165945 Saitama-shi Saitama
Japan Toho University Sakura Medical Center /ID# 165949 Sakura-shi Chiba
Japan Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital /ID# 165943 Sapporo-shi Hokkaido
Japan Sapporo Medical University Hospital /ID# 167137 Sapporo-shi Hokkaido
Japan Tohoku University Hospital /ID# 167135 Sendai-shi Miyagi
Japan Tokyo Women's Medical University Hospital /ID# 205981 Shinjuku-ku Tokyo
Japan Osaka University Hospital /ID# 169662 Suita-shi Osaka
Japan NHO Shizuoka Medical Center /ID# 167138 Sunto-gun Shizuoka
Japan National Hospital Organization Takasaki General Medical Center /ID# 167136 Takasaki-shi Gunma
Japan Osaka Medical and Pharmaceutical University Hospital /ID# 206324 Takatsuki-shi Osaka
Japan Toyama Prefectural Central Hospital /ID# 217833 Toyama-shi Toyama
Japan Toyohashi Municipal Hospital /ID# 200174 Toyohashi-shi Aichi
Japan Japanese Red Cross Wakayama Medical Center /ID# 200638 Wakayama-shi Wakayama
Japan Wakayama Medical University Hospital /ID# 169481 Wakayama-shi Wakayama
Japan Yamagata University Hospital /ID# 200156 Yamagata-shi Yamagata
Japan Kenseikai Dongo Hospital /ID# 208103 Yamatotakada-shi Nara
Japan Yokkaichi Hazu Medical Center /ID# 167191 Yokkaichi-shi Mie
Korea, Republic of Dong-A University Hospital /ID# 167582 Busan
Korea, Republic of Inje University Haeundae Hospital /ID# 202629 Busan
Korea, Republic of Pusan National University Hospital /ID# 167580 Busan
Korea, Republic of Kyungpook National Univ Hosp /ID# 207015 Daegu
Korea, Republic of Hayang University GuriHospital /ID# 167578 Guri Gyeonggido
Korea, Republic of CHA University Bundang Medical Center /ID# 167583 Seongnam si Gyeonggido
Korea, Republic of Chung-Ang University Hostipal /ID# 207017 Seoul
Korea, Republic of Kangbuk Samsung Hospital /ID# 167577 Seoul Seoul Teugbyeolsi
Korea, Republic of Samsung Medical Center /ID# 167579 Seoul
Korea, Republic of Yonsei University Health System Severance Hospital /ID# 167581 Seoul Seoul Teugbyeolsi
Latvia Digestive Disease Center Gastro /ID# 169517 Riga
Latvia Pauls Stradins Clinical University Hospital /ID# 169493 Riga
Latvia Riga East Clinical University Hospital /ID# 169496 Riga
Lithuania Hospital of Lithuanian University of Health Sciences Kaunas Clinics /ID# 207263 Kaunas
Lithuania Vilnius University Hospital Santaros Klinikos /ID# 203285 Vilnius
Malaysia Hospital Sultanah Bahiyah /ID# 202627 Alor Setar Kedah
Malaysia Universiti Kebangsaan Malaysia (UKM) Medical Centre /ID# 170778 Kuala Lumpur Selangor
Mexico Clinica de Investigacion en Reumatologia y Obesidad S.C. /ID# 206779 Guadalajara Jalisco
Mexico Morales Vargas Centro de Investigacion S.C. /ID# 203495 Leon Guanajuato
Mexico Instituto de Investigaciones Aplicadas a la Neurociencias A.C. /ID# 207143 Victoria de Durango Durango
Netherlands Academisch Medisch Centrum /ID# 166924 Amsterdam
Netherlands Medisch Spectrum Twente /ID# 170297 Enschede
Netherlands Zuyderland Medisch Centrum /ID# 169698 Heerlen Limburg
Netherlands Radboud Universitair Medisch Centrum /ID# 166925 Nijmegen Gelderland
Poland Malopolskie Centrum Kliniczne /ID# 202166 Krakow Malopolskie
Poland Centrum Medyczne Reuma Park w Warszawie /ID# 200488 Warsaw Mazowieckie
Poland WIP Warsaw IBD Point Profesor Kierkus /ID# 224300 Warsaw Mazowieckie
Poland Centrum Zdrowia MDM /ID# 200486 Warszawa Mazowieckie
Poland Vistamed /ID# 208570 Wroclaw Dolnoslaskie
Portugal Hospital Garcia de Orta, EPE /ID# 170234 Almada
Portugal Hospital da Senhora da Oliveira Guimaraes, EPE /ID# 170225 Guimaraes Braga
Portugal Hospital Egas Moniz /ID# 170249 Lisbon Porto
Portugal Unidade Local de Saúde do Alto Minho, EPE - Hospital Conde de Bertiandos /ID# 200606 Ponte de Lima Viana Do Castelo
Portugal Centro Hospitalar Universitario de Sao Joao, EPE /ID# 170231 Porto
Puerto Rico Mindful Medical Research /ID# 203357 San Juan
Puerto Rico School of Medicine University of Puerto Rico-Medical Science Campus /ID# 166770 San Juan
Romania Clinica GASTRO MED SRL /ID# 206367 Cluj-Napoca Cluj
Romania Institutul Clinic Fundeni /ID# 167826 Sector 2 Bucuresti
Romania Cabinet Particular Policlinic Algomed /ID# 167827 Timi?oara
Russian Federation Immanuel Kant Baltic Federal University /ID# 202128 Kaliningrad Kaliningradskaya Oblast
Russian Federation Kazan State Medical University /ID# 169574 Kazan Tatarstan, Respublika
Russian Federation Olla-Med Clinic /ID# 208721 Moscow
Russian Federation P.A. Bayandin Murmansk Regiona /ID# 169575 Murmansk
Russian Federation LLC Medical Center /ID# 209233 Novosibirsk Novosibirskaya Oblast
Russian Federation Perm Clinical Center of the Federal Medical and Biological Agency /ID# 202988 Perm Permskiy Kray
Russian Federation Republican hospital named after V.A. Baranov /ID# 206487 Petrozavodsk
Russian Federation Euromedservice /ID# 206609 Pushkin
Russian Federation LLC Novaya Klinika /ID# 206615 Pyatigorsk Stavropol Skiy Kray
Russian Federation X7 Clinical Research Center /ID# 216349 Saint Petersburg
Russian Federation City Clinical Hospital No. 31 /ID# 208870 St. Petersburg
Russian Federation Professor Pasechnikov Gastroenterology and Pankreatology clinic /ID# 202995 Stavropol Stavropol Skiy Kray
Serbia Clin Hosp Ctr Bezanijska Kosa /ID# 168799 Belgrade Beograd
Serbia Clinical Hosp Center Zvezdara /ID# 168221 Belgrade Beograd
Serbia Military Medical Academy /ID# 168784 Belgrade Beograd
Serbia University Clinical Center Serbia /ID# 168220 Belgrade Beograd
Serbia University Clinical Center Kragujevac /ID# 205858 Kragujevac Sumadijski Okrug
Serbia Clinical Center Vojvodina /ID# 168222 Novi Sad Vojvodina
Singapore Gleneagles Medical Centre /ID# 206530 Singapore
Singapore KL Ling Gastroenterology and Liver Clinic /ID# 217963 Singapore
Singapore Tan Tock Seng Hospital /ID# 203159 Singapore
Slovakia Fakultna nemocnica s poliklinikou F.D. Roosevelta Banska Bystrica /ID# 169952 Banska Bystrica
Slovakia KM Management, spol. s.r.o. /ID# 170199 Nitra
Slovenia Univ Medical Ctr Ljubljana /ID# 211042 Ljubljana
South Africa Farmovs (Pty) Ltd /Id# 207536 Bloemfontein Free State
South Africa Dr JP Wright /ID# 170885 Cape Town Western Cape
South Africa Private Practice Dr MN Rajabally /ID# 169852 Cape Town Western Cape
South Africa Lenasia Clinical Trial Centre /ID# 205144 Johannesburg Gauteng
South Africa Wits Clinical Research Site /ID# 170851 Johannesburg Gauteng
Spain Hospital Universitario A Coruna - CHUAC /ID# 203908 A Coruna
Spain Hospital Clinic de Barcelona /ID# 171242 Barcelona
Spain Hospital Universitario Vall d'Hebron /ID# 171237 Barcelona
Spain Hospital Universitario de Girona Doctor Josep Trueta /ID# 202040 Girona
Spain Hospital Juan Ramon Jimenez /ID# 171243 Huelva
Spain Hospital Universitario Dr. Negrin /ID# 171238 Las Palmas de Gran Canaria Las Palmas
Spain Hospital Universitario La Paz /ID# 171241 Madrid
Spain Hospital Universitari Son Espases /ID# 201997 Palma de Mallorca Illes Balears
Spain Complejo Hospitalario de Navarra /ID# 202038 Pamplona Navarra
Spain Hospital Unversitario Marques de Valdecilla /ID# 202039 Santander Cantabria
Spain Hospital Universitario Virgen Macarena /ID# 171240 Sevilla
Spain Hospital Universitario y Politecnico La Fe /ID# 201988 Valencia
Sweden Alingsas lasarett /ID# 170838 Alingsas Vastra Gotalands Lan
Sweden Sodra Alvsborgs sjukhus /ID# 202889 Boras Vastra Gotalands Lan
Sweden Sahlgrenska University Hospital /ID# 169031 Gothenburg Vastra Gotalands Lan
Sweden Hallands Hospital Halmstad /ID# 170840 Halmstad Hallands Lan
Switzerland Inselspital, Universitätsspital Bern /ID# 171006 Bern
Switzerland Universitätsspital Zürich /ID# 170999 Zürich Zuerich
Taiwan National Taiwan University Hospital /ID# 169789 Taipei City
Taiwan Linkou Chang Gung Memorial Ho /ID# 169788 Taoyuan City
Turkey Ankara Univ Medical Faculty /ID# 206412 Ankara
Turkey Inonu Universitesi Turgut Ozal /ID# 201267 Battalgazi/malatya
Turkey Mustafa Kemal University Medic /ID# 171318 Hatay
Turkey Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty /ID# 200280 Istanbul
Turkey Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi /ID# 171316 Istanbul
Turkey Acibadem Kozyatagi Hospital /ID# 209405 Kadikoy Istanbul
Turkey Erciyes University Medical Fac /ID# 171321 Melikgazi Kayseri
Turkey Mersin University Medical /ID# 171320 Mersin
Turkey Sisli Etfal Train & Res Hosp /ID# 171317 Sisli
Turkey Gazi Universitesi Tip Fakultes /ID# 217443 Yenimahalle
United Kingdom Royal United Hospitals Bath /ID# 169084 Bath
United Kingdom South Eastern Health and Social Care Trust /ID# 205322 Belfast Antrim
United Kingdom University Hospitals Birmingham NHS Foundation Trust /ID# 169080 Birmingham
United Kingdom The Dudley Group NHS Foundation Trust /ID# 169079 Dudley
United Kingdom London North West University Healthcare NHS Trust /ID# 169078 Harrow
United Kingdom Barts Health NHS Trust /ID# 218829 London London, City Of
United Kingdom King's College Hospital NHS Foundation Trusts /ID# 169082 London
United Kingdom The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 169085 Newcastle Upon Tyne
United Kingdom Stockport NHS foundation trust /ID# 208718 Stockport
United Kingdom Taunton and Somerset NHS Foundation Trust /ID# 209664 Taunton
United Kingdom St George's University Hospitals NHS Foundation Trust /ID# 205551 Tooting
United Kingdom Warrington and Halton Hospitals NHS Foundation Trust /ID# 171388 Warrington Cheshire West And Chester
United Kingdom Warrington and Halton Hospitals NHS Foundation Trust /ID# 209085 Warrington Cheshire West And Chester
United Kingdom The Royal Wolverhampton NHS Trust /ID# 171387 Wolverhampton
United States University of Michigan Health Systems /ID# 164844 Ann Arbor Michigan
United States TX Clinical Research Institute /ID# 164848 Arlington Texas
United States Johns Hopkins University School of Medicine /ID# 211940 Baltimore Maryland
United States Inquest Clinical Research /ID# 164865 Baytown Texas
United States Washington Gastroenterology Associates /ID# 164721 Bellevue Washington
United States HP Clinical Research /ID# 164929 Bountiful Utah
United States Advantage Clinical Trials /ID# 168557 Bronx New York
United States Montefiore Medical Center - Moses Campus /ID# 166226 Bronx New York
United States NY Scientific /ID# 164833 Brooklyn New York
United States Lahey Hospital and Medical Center /ID# 214725 Burlington Massachusetts
United States Texas Digestive Disease Consultants /ID# 209802 Cedar Park Texas
United States Texas Digestive Disease Consultants /ID# 209952 Cedar Park Texas
United States Delsol Research Management, Ll /Id# 170179 Chandler Arizona
United States Pharmacorp Clinical Trials /ID# 164809 Charleston South Carolina
United States Atrium Health Carolinas Medical Center /ID# 164834 Charlotte North Carolina
United States PMG Research of Charlotte /ID# 171170 Charlotte North Carolina
United States Clin Res Inst of Michigan, LLC /ID# 170178 Chesterfield Michigan
United States MGG Group Co, Inc.Chevy Chase Clinical Research /ID# 164835 Chevy Chase Maryland
United States University of Chicago Medicine /ID# 165472 Chicago Illinois
United States Consultants for Clinical Research /ID# 164855 Cincinnati Ohio
United States University of Cincinnati /ID# 164720 Cincinnati Ohio
United States Clinical Research of West Florida, Inc /ID# 205825 Clearwater Florida
United States Clinical Research of West Florida, Inc /ID# 208117 Clearwater Florida
United States Cleveland Clinic Main Campus /ID# 208220 Cleveland Ohio
United States Delta Waves, Inc. /ID# 164872 Colorado Springs Colorado
United States Peak Gastroenterology Associates, PC /ID# 170181 Colorado Springs Colorado
United States Gastro Center of Maryland /ID# 171171 Columbia Maryland
United States Optimed Research, Ltd. /ID# 205618 Columbus Ohio
United States The Ohio State University /ID# 170174 Columbus Ohio
United States Advanced Research - Coral Springs /ID# 218020 Coral Springs Florida
United States Southern California Res. Ctr. /ID# 169654 Coronado California
United States Citrus Valley Gastroenterology /ID# 166201 Covina California
United States Tri-State Gastroenterology /ID# 165484 Crestview Hills Kentucky
United States Hometown Urgent Care and Resea /ID# 201290 Dayton Ohio
United States DuPage Medical Group /ID# 205303 Downers Grove Illinois
United States AGA Clinical Research Associates, LLC /ID# 164883 Egg Harbor Township New Jersey
United States Dayton Gastroenterology, Inc. /ID# 167624 Englewood Ohio
United States MediSphere Medical Research Center /ID# 166209 Evansville Indiana
United States Plains Clinical Research Center, LLC /ID# 170184 Fargo North Dakota
United States Digestive Health Associates (DHA) - Farmington Hills /ID# 206099 Farmington Hills Michigan
United States Gastro One /ID# 164718 Germantown Tennessee
United States Gastroenterology Associates, P.A. of Greenville /ID# 164880 Greenville South Carolina
United States Medical Research Center of CT /ID# 164829 Hamden Connecticut
United States CroNOLA, LLC /ID# 164722 Houma Louisiana
United States Baylor College of Medicine - Baylor Medical Center /ID# 164847 Houston Texas
United States Centex Studies, Inc. - Houston /ID# 201213 Houston Texas
United States CliniCore International, LLC /ID# 164662 Houston Texas
United States GI Specialists of Houston /ID# 202338 Houston Texas
United States Indianapolis Gastroenterology /ID# 164837 Indianapolis Indiana
United States University of Iowa Hospitals and Clinics /ID# 165330 Iowa City Iowa
United States Southern Therapy and Advanced Research (STAR) LLC /ID# 165318 Jackson Mississippi
United States Encore Borland-Groover Clinical Research /Id# 203498 Jacksonville Florida
United States East Tennessee Research Institute /ID# 203612 Johnson City Tennessee
United States NYU Langone Long Island Clinical Research Associates /ID# 164830 Lake Success New York
United States Las Vegas Medical Research /ID# 168562 Las Vegas Nevada
United States United Medical Doctors /ID# 207452 Los Alamitos California
United States Gastrointestinal Biosciences Clinical Trials, LLC /ID# 164887 Los Angeles California
United States University of Louisville /ID# 168536 Louisville Kentucky
United States University of Louisville /ID# 208093 Louisville Kentucky
United States Caprock Gastro Research /ID# 215437 Lubbock Texas
United States Gastroenterology Associates of Central Georgia, LLC /ID# 165460 Macon Georgia
United States Ctr for Advanced Gastroenterol /ID# 165332 Maitland Florida
United States Great Lakes Medical Research, LLC /ID# 202007 Mentor Ohio
United States Coral Research Clinic /ID# 164657 Miami Florida
United States Crystal Pharmacology Research /ID# 166101 Miami Florida
United States Froedtert Memorial Lutheran Hospital /ID# 202286 Milwaukee Wisconsin
United States Facey Medical Foundation /ID# 203137 Mission Hills California
United States CB Flock Research Corporation /ID# 166220 Mobile Alabama
United States East View Medical Research, LLC /ID# 171133 Mobile Alabama
United States United Medical Doctors - Murrieta /ID# 164845 Murrieta California
United States Quality Medical Research /ID# 205262 Nashville Tennessee
United States Vanderbilt University Medical Center /ID# 164846 Nashville Tennessee
United States Aquiant Research /ID# 205504 New Albany Indiana
United States Rutgers Robert Wood Johnson /ID# 166092 New Brunswick New Jersey
United States Nola Research Works, LLC /ID# 164897 New Orleans Louisiana
United States Advanced Research Institute, Inc /ID# 164814 New Port Richey Florida
United States Columbia Univ Medical Center /ID# 164870 New York New York
United States The Mount Sinai Hospital /ID# 170172 New York New York
United States Advanced Research Institute /ID# 164866 Ogden Utah
United States Digestive Disease Specialists /ID# 201062 Oklahoma City Oklahoma
United States CHI Health Research Center /ID# 168545 Omaha Nebraska
United States Quality Clinical Research Inc. /ID# 170177 Omaha Nebraska
United States Endoscopic Research, Inc. /ID# 205893 Orlando Florida
United States Omega Research Maitland, LLC /ID# 203480 Orlando Florida
United States Thomas Jefferson University /ID# 168014 Philadelphia Pennsylvania
United States University of Pennsylvania /ID# 168402 Philadelphia Pennsylvania
United States Wake Radiology UNC REX Healthcare - Raleigh Office /ID# 164663 Raleigh North Carolina
United States Rapid City Medical Center - GI Research /ID# 201734 Rapid City South Dakota
United States Gastro Group of Rochester /ID# 166216 Rochester New York
United States Mayo Clinic - Rochester /ID# 164868 Rochester Minnesota
United States Gastroenterology Consultants PC - Roswell /ID# 218219 Roswell Georgia
United States Duplicate_Care Access Research /ID# 164853 Salt Lake City Utah
United States Clinical Associates in Research Therapeutics of America, LLC /ID# 164863 San Antonio Texas
United States Southern Star Research Institute, LLC /ID# 169754 San Antonio Texas
United States Medical Assoc Research Grp /ID# 169705 San Diego California
United States Ucsd /Id# 164679 San Diego California
United States UCSF Center for Colitis and Crohn's Disease /ID# 202373 San Francisco California
United States Univ of California San Francis /ID# 164843 San Francisco California
United States Care Access Research /ID# 167766 San Pablo California
United States HonorHealth Research Institute - Shea /ID# 164734 Scottsdale Arizona
United States University of Washington /ID# 164875 Seattle Washington
United States Virginia Mason - Seattle Orthapedics /ID# 164680 Seattle Washington
United States Louisana Research Center, LLC /ID# 164659 Shreveport Louisiana
United States Richmond University Medical Center /ID# 201855 Staten Island New York
United States Carl R. Meisner Medical Clinic /ID# 201060 Sugar Land Texas
United States Arizona Arthritis & Rheumatology Research, PLLC /ID# 203891 Sun City Arizona
United States Atlanta Gastroenterology Spec /ID# 164780 Suwanee Georgia
United States AdventHealth Tampa /ID# 171175 Tampa Florida
United States Clinical Research Trials of Florida, Inc. /ID# 203484 Tampa Florida
United States Center for Digestive Health /ID# 164733 Troy Michigan
United States Healthcare Research Consultant /ID# 166228 Tulsa Oklahoma
United States Options Health Research, LLC /ID# 164737 Tulsa Oklahoma
United States Tyler Research Institute, LLC /ID# 168681 Tyler Texas
United States The Vancouver Clinic, INC. PS /ID# 164811 Vancouver Washington
United States Gastro Health & Nutrition - Victoria /ID# 167813 Victoria Texas
United States Allegiance Research Specialists /ID# 165321 Wauwatosa Wisconsin
United States Velocity Clinical Research - Salt Lake City /ID# 166095 West Jordan Utah
United States Duplicate_Western States Clinical Research, Inc. /ID# 164895 Wheat Ridge Colorado
United States Wake Forest Baptist Medical Center /ID# 201225 Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
AbbVie

Countries where clinical trial is conducted

United States,  Argentina,  Australia,  Austria,  Belgium,  Bosnia and Herzegovina,  Brazil,  Bulgaria,  Canada,  Chile,  China,  Colombia,  Croatia,  Czechia,  Denmark,  Egypt,  Estonia,  France,  Germany,  Greece,  Hong Kong,  Hungary,  Ireland,  Israel,  Italy,  Japan,  Korea, Republic of,  Latvia,  Lithuania,  Malaysia,  Mexico,  Netherlands,  Poland,  Portugal,  Puerto Rico,  Romania,  Russian Federation,  Serbia,  Singapore,  Slovakia,  Slovenia,  South Africa,  Spain,  Sweden,  Switzerland,  Taiwan,  Turkey,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Participants With Clinical Remission Per Crohn's Disease Activity Index (CDAI) at Week 12 The CDAI was used to evaluate the activity of Crohn's disease. Clinical remission per CDAI is defined as CDAI <150. The CDAI is calculated on the basis of a one-week evaluation of 8 items: frequency of liquid or very soft stool, abdominal pain, complications of Crohn's disease (e.g., uveitis, arthritis, fistula, and abscess), abdominal mass, hematocrit, body weight, use of antidiarrheals, and general condition. Total score ranges from 0 to about 600. Higher CDAI scores indicate more severe disease. CDAI scores below 150 represent remission and scores over 450 represent very severe Crohn's disease. Results were based on non-responder imputation incorporating multiple imputation to handle missing data due to COVID-19 (NRI-C). Week 12
Primary Percentage of Participants With Endoscopic Response at Week 12 Endoscopic response was defined as greater than 50% decrease in Simple Endoscopic Score for Crohn's Disease (SES-CD) from Baseline of the induction study (or for participants with an SES-CD of 4 at Baseline of the induction study, at least a 2-point reduction from Baseline), as scored by Central Reviewer. SES-CD is calculated based on the sum of individual segment values for four endoscopic variables (presence and size of ulcers, ulcerated surface, affected surface and presence of narrowing). Each variable in each segment is scored 0 to 3 resulting in SES-CD values ranging from 0 to 56 with higher scores indicating more severe disease. Results were based on NRI-C. Baseline to Week 12
Primary Number of Participants With Adverse Events An adverse event (AE) is defined as any untoward medical occurrence in a patient or clinical investigation participant administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not the event is considered causally related to the use of the product. From first dose of study drug until 30 days following last dose of study drug (up to approximately 28 weeks)
Secondary Percentage of Participants With Clinical Remission Per Patient-Reported Outcomes (PROs) at Week 12 Clinical remission per PROs was defined as average daily very soft or liquid stool frequency (SF) =2.8 and average daily abdominal pain (AP) score =1.0 and both not greater than Baseline. The number of soft or liquid stools and abdominal pain rated on a scale of 0=none to 3=severe were recorded in an electronic diary. Results were based on NRI-C. Baseline to Week 12
Secondary Percentage of Participants With Endoscopic Remission at Week 12 Endoscopic remission was defined per SES-CD. SES-CD =4 and at least 2-point reduction from Baseline and no subscore >1 in any individual variable, as scored by Central Reviewer. SES-CD is calculated based on the sum of individual segment values for four endoscopic variables (presence and size of ulcers, ulcerated surface, affected surface and presence of narrowing). Each variable in each segment is scored 0 to 3 resulting in SES-CD values ranging from 0 to 56 with higher scores indicating more severe disease. Results were based on NRI-C. Baseline to Week 12
Secondary Percentage of Participants Who Discontinued Corticosteroid Use for Crohn's Disease (CD) and Achieved Clinical Remission Per CDAI at Week 12, in Participants Taking Corticosteroids at Baseline As prespecified in the protocol, this outcome measure was planned to be assessed in participants taking corticosteroids at Baseline. Clinical remission per CDAI: CDAI <150. The CDAI is used to evaluate the activity of Crohn's disease. The CDAI is calculated on the basis of a one-week evaluation of 8 items: frequency of liquid or very soft stool, abdominal pain, complications of Crohn's disease (e.g., uveitis, arthritis, fistula, and abscess), abdominal mass, hematocrit, body weight, use of antidiarrheals, and general condition. Total score ranges from 0 to about 600. Higher CDAI scores indicate more severe disease. CDAI scores below 150 represent remission and scores over 450 represent very severe Crohn's disease. Results were based on NRI-C. Week 12
Secondary Change From Baseline in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Total Score at Week 12 The FACIT-F questionnaire was developed to assess fatigue associated with anemia. It consists of 13 fatigue-related questions. The responses to the 13 items on the FACIT-F questionnaire are each measured on a 5-point Likert scale. The responses to the answers are the following: 0= not at all; 1= a little bit; 2= somewhat; 3= quite a bit; 4=very much. Thus, the total score ranges from 0 to 52. High scores represent less fatigue. A positive change from Baseline indicates improvement. Baseline and Week 12
Secondary Change From Baseline in Inflammatory Bowel Disease Questionnaire (IBDQ) Total Score at Week 12 The IBDQ is a disease-specific instrument composed of 32 Likert-scaled items. The IBDQ scale contains 4 component subscales: bowel symptoms (10 items), systemic symptoms (5 items), emotional function (12 items), and social function(5 items). Each item is scored on a 7-point scale where: 1=worst to 7= best. The total score ranges from 32 to 224, with higher scores indicating better health-related quality of life. A positive change from Baseline indicates improvement. Baseline and Week 12
Secondary Percentage of Participants Achieving Clinical Response 100 (CR-100) at Week 2 CR-100 is defined as a decrease of at least 100 points in CDAI from Baseline at Week 2. The CDAI is used to evaluate the activity of Crohn's disease. The CDAI is calculated on the basis of a one-week evaluation of 8 items: frequency of liquid or very soft stool, abdominal pain, complications of Crohn's disease (e.g., uveitis, arthritis, fistula, and abscess), abdominal mass, hematocrit, body weight, use of antidiarrheals, and general condition. Total score ranges from 0 to about 600. Higher CDAI scores indicate more severe disease. CDAI scores below 150 represent remission and scores over 450 represent very severe Crohn's disease. Results were based on NRI-C. Baseline to Week 2
Secondary Percentage of Participants Achieving Clinical Response 100 (CR-100) at Week 12 CR-100 is defined as a decrease of at least 100 points in CDAI from Baseline at Week 12. The CDAI is used to evaluate the activity of Crohn's disease. The CDAI is calculated on the basis of a one-week evaluation of 8 items: frequency of liquid or very soft stool, abdominal pain, complications of Crohn's disease (e.g., uveitis, arthritis, fistula, and abscess), abdominal mass, hematocrit, body weight, use of antidiarrheals, and general condition. Total score ranges from 0 to about 600. Higher CDAI scores indicate more severe disease. CDAI scores below 150 represent remission and scores over 450 represent very severe Crohn's disease. Results were based on NRI-C. Baseline to Week 12
Secondary Percentage of Participants With Clinical Remission Per Crohn's Disease Activity Index (CDAI) at Week 4 The CDAI was used to evaluate the activity of Crohn's disease. Clinical remission per CDAI is defined as CDAI <150. The CDAI is calculated on the basis of a one-week evaluation of 8 items: frequency of liquid or very soft stool, abdominal pain, complications of Crohn's disease (e.g., uveitis, arthritis, fistula, and abscess), abdominal mass, hematocrit, body weight, use of antidiarrheals, and general condition. Total score ranges from 0 to 600. Higher CDAI scores indicate more severe disease. CDAI scores below 150 represent remission and scores over 450 represent very severe Crohn's disease. Results were based on NRI-C. Week 4
Secondary Percentage of Participants With Hospitalizations Due to Crohn's Disease (CD) During Part 1 (12-week Double-blind Induction Period) Up to Week 12 in Part 1: Double-blind Induction Period
Secondary Percentage of Participants With Resolution of Extra-Intestinal Manifestations (EIMs) at Week 12, in Participants With EIMs at Baseline EIMs are defined as manifestations of Crohn's disease in areas of the body other than the digestive tract, including eyes, skin, joints, mouth, and liver. Results were based on NRI-C. Week 12
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03815851 - Relationship Between Prophylactic Drainage and Postoperative Complications (PPOI) in Crohn's Patients After Surgery N/A
Not yet recruiting NCT06100289 - A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease Phase 3
Completed NCT02883452 - A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis Phase 1
Recruiting NCT04777656 - Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients. Phase 3
Terminated NCT03017014 - A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions
Recruiting NCT05428345 - A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Recruiting NCT06053424 - Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease Phase 1
Completed NCT02508012 - Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases N/A
Terminated NCT02882841 - MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients N/A
Not yet recruiting NCT02858557 - The Effect of Diet on Microbial Profile and Disease Outcomes in Patients With Inflammatory Bowel Diseases N/A
Terminated NCT02417974 - Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT) Phase 2
Completed NCT02542917 - Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study
Completed NCT03010787 - A First Time in Human Study in Healthy Volunteers and Patients Phase 1
Active, not recruiting NCT02316678 - Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics N/A
Completed NCT02197780 - Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD N/A
Completed NCT02154425 - A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers Phase 1
Completed NCT02265588 - Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD). N/A
Completed NCT02193048 - Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease
Recruiting NCT02395354 - Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease N/A
Completed NCT01958827 - A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease Phase 3